| Dr Amanda Lea Robinson, DO | |
|
2051 Hamill Rd, Hixson, TN 37343-6614 | |
| (423) 495-7404 | |
| (423) 495-2625 |
| Full Name | Dr Amanda Lea Robinson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 2051 Hamill Rd, Hixson, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750776639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 3932 (Tennessee) | Secondary |
| 207R00000X | Internal Medicine | DO.1847 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Health Partners Foundation, Inc | 8022919570 | 303 |
News Archive
Feinstein Institute for Medical Research Assistant Professor Amit Baumel, PhD, has developed Enlight, a tool to evaluate the quality and therapeutic potential of computer and mobile-based eHealth applications.
A team of investigators at the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Changes to standard urine orders in a computer physician order entry (CPOE) system, resulted in a 45% reduction in unnecessary urine cultures ordered, a change that is expected prevent unnecessary treatment of asymptomatic patients whose bacteria counts are above normal.
EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission aimed at advancing transnational research in Nanomedicine, announced today the projects that will be funded following its 2nd joint transnational call for collaborative research projects. Eight projects, involving 46 partners from 10 countries will be funded with €8 Million provided by EuroNanoMed partners. The research projects were chosen from 33 applications involving 178 applicant groups from 19 EU member and associated states/regions.
Previous research identified the interferon-responsive OAS1 gene as a risk gene for Alzheimer's disease. OAS1 is an enzyme that binds to double-stranded RNA and induces the conformation to create oligoadenylates. They also activate RNase L to break down RNA.
› Verified 4 days ago
| Entity Name | Memorial Health Partners Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922053545 PECOS PAC ID: 8022919570 Enrollment ID: O20040116000823 |
News Archive
Feinstein Institute for Medical Research Assistant Professor Amit Baumel, PhD, has developed Enlight, a tool to evaluate the quality and therapeutic potential of computer and mobile-based eHealth applications.
A team of investigators at the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Changes to standard urine orders in a computer physician order entry (CPOE) system, resulted in a 45% reduction in unnecessary urine cultures ordered, a change that is expected prevent unnecessary treatment of asymptomatic patients whose bacteria counts are above normal.
EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission aimed at advancing transnational research in Nanomedicine, announced today the projects that will be funded following its 2nd joint transnational call for collaborative research projects. Eight projects, involving 46 partners from 10 countries will be funded with €8 Million provided by EuroNanoMed partners. The research projects were chosen from 33 applications involving 178 applicant groups from 19 EU member and associated states/regions.
Previous research identified the interferon-responsive OAS1 gene as a risk gene for Alzheimer's disease. OAS1 is an enzyme that binds to double-stranded RNA and induces the conformation to create oligoadenylates. They also activate RNase L to break down RNA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Lea Robinson, DO Po Box 116638, Atlanta, GA 30368-6638 Ph: (423) 495-7404 | Dr Amanda Lea Robinson, DO 2051 Hamill Rd, Hixson, TN 37343-6614 Ph: (423) 495-7404 |
News Archive
Feinstein Institute for Medical Research Assistant Professor Amit Baumel, PhD, has developed Enlight, a tool to evaluate the quality and therapeutic potential of computer and mobile-based eHealth applications.
A team of investigators at the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Changes to standard urine orders in a computer physician order entry (CPOE) system, resulted in a 45% reduction in unnecessary urine cultures ordered, a change that is expected prevent unnecessary treatment of asymptomatic patients whose bacteria counts are above normal.
EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission aimed at advancing transnational research in Nanomedicine, announced today the projects that will be funded following its 2nd joint transnational call for collaborative research projects. Eight projects, involving 46 partners from 10 countries will be funded with €8 Million provided by EuroNanoMed partners. The research projects were chosen from 33 applications involving 178 applicant groups from 19 EU member and associated states/regions.
Previous research identified the interferon-responsive OAS1 gene as a risk gene for Alzheimer's disease. OAS1 is an enzyme that binds to double-stranded RNA and induces the conformation to create oligoadenylates. They also activate RNase L to break down RNA.
› Verified 4 days ago
Dr. Jessica Grace Huffstutter, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 Executive Dr, Hixson, TN 37343 Phone: 423-826-0800 Fax: 423-826-0810 | |
Melanie Black Blake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1008 Executive Dr Ste 104, Hixson, TN 37343 Phone: 423-497-5363 | |
Thomas A Cook, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2051 Hamill Rd, Suite 204, Hixson, TN 37343 Phone: 423-870-2450 Fax: 423-877-5208 | |
Dr. John C Wood, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2051-b Hamill Road, Suite 103, Hixson, TN 37343 Phone: 423-756-8871 Fax: 423-475-8976 | |
Kathryn T Dinh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5104 Hixson Pike, Hixson, TN 37343 Phone: 423-818-9790 Fax: 423-697-7696 | |
Dr. Walter Douglas Parkhurst, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4980 Alpha Ln, Hixson, TN 37343 Phone: 423-870-2450 Fax: 423-877-5208 | |
Young Seong Chang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2051 Hamill Rd, Hixson, TN 37343 Phone: 423-495-2620 Fax: 423-495-2625 |